Tag: biotech
India puts 86 crore behind four AI designed drug candidates
India's Technology Development Board approved 86 crore rupees of support for Peptris, which will push four AI-discovered molecules into preclinical…
Arrowhead’s RNA drug cuts Alzheimer’s tau by 73% in early trial
Arrowhead reported interim Phase 1/2a data showing its injectable RNA therapy crossed the blood-brain barrier and cut cerebrospinal tau by…
Undecimal Bio raises $18M to push RNA drugs past the liver
Undecimal Bio has raised $18 million in Seed funding to deliver RNA-based medicines to organs beyond the liver, where RNAi…
Google and US government back $1.8B cell-modeling push
A Zuckerberg-founded nonprofit is assembling $1.8B for open biological AI data, backed by $300M from three tech partners and $500M…
Talus skips protein folding to screen 3.4 billion compounds
A Seattle startup says its structure-free model matches drugs to hard targets in milliseconds, sidestepping a blind spot in folding…
A first patient receives Generate’s AI-designed cell therapy for ovarian cancer
Generate Biomedicines and Roswell Park have dosed the first patient with GB-5267, an armored CAR T built with AI to…
AI shrinks drug discovery timelines with data-driven biologics design
MIT Technology Review explores how AstraZeneca and others use AI to compress drug discovery and target previously untreatable diseases.
Over 173 AI-designed drugs now in trials as FDA decision nears
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…